Predictors of Survival Without Intestinal Resection after First-Line Endovascular Revascularization in Patients with Acute Arterial Mesenteric Ischemia
Lorenzo Garzelli, Raphael Dufay, Arnaud Tual, Olivier Corcos, Dominique Cazals‐Hatem, Valérie Vilgrain, Alexandre Nuzzo, Iannis Ben Abdallah, Maxime Ronot
Abstract
= .002). The 30-day IRF survival was 86%, 61%, 47%, and 23% in patients with both favorable features, persistent bowel enhancement but CRP level greater than 100 mg/L, no bowel enhancement but CRP level less than 100 mg/L, and both unfavorable features, respectively. Conclusion Independent predictors associated with 30-day IRF survival in patients with acute arterial mesenteric ischemia whose first-line treatment was endovascular revascularization were persistent bowel wall enhancement at initial CT and CRP level less than 100 mg/L. © RSNA, 2024
Topics & Concepts
MedicineRevascularizationMesenteric ischemiaSurgeryBowel resectionIschemiaSurvival rateRetrospective cohort studyInternal medicineRadiologyMyocardial infarctionAbdominal vascular conditions and treatmentsBiliary and Gastrointestinal FistulasGallbladder and Bile Duct Disorders